"Rețeaua de sănătate REGINA MARIA este liderul serviciilor medicale private din România."

During the past decade, Euroclinic Center of Oncology SRL conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Euroclinic Center of Oncology SRL" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Pfizer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Euroclinic Center of Oncology SRL" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Euroclinic Center of Oncology SRL" are "Breast Cancer" (3 trials), "Crohn's Disease" (3 trials), "Systemic Lupus Erythematosus" (3 trials), "Ulcerative Colitis" (3 trials) and "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Euroclinic Center of Oncology SRL" in a lesser frequency.

Most popular intervention types in "Euroclinic Center of Oncology SRL" are "Drug" (21 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Etrasimod" (4 trials), "Baricitinib" (3 trials), "Pertuzumab" (3 trials) and "Trastuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Euroclinic Center of Oncology SRL" are 19 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Euroclinic Center of Oncology SRL". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Euroclinic Center of Oncology SRL, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Euroclinic Center of Oncology SRL, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".